| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | BURLINGTON STORES INC | May 2, 2023 | |
| Sell | BioLife Solutions, Inc. | Dec 12, 2022 | |
| Buy | BioLife Solutions, Inc. | Nov 8, 2022 | |
| Buy | Biolife Solutions, Inc. | Jul 7, 2020 | |
| Buy | BioLife Solutions Inc NEW | Dec 8, 2019 | |
| Buy | BIOLIFE SOLUTIONS INC CMN | Feb 27, 2018 |
This page tracks congressional stock trading activity in BioLife Solutions, Inc. (BLFS) in the Healthcare sector. Disclosed Capitol has indexed 6 disclosed congressional trades involving BLFS. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of June 2023 — Disclosed Capitol has tracked 6 disclosed congressional trades in BioLife Solutions, Inc. (BLFS) — 2:2 buy-heavy ratio — led by Christopher L. Jacobs (R).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| May 2, 2023 | Michael McCaul | R | Sale | $1,001 - $15,000 |
| Dec 12, 2022 | Christopher L. Jacobs | R | Sale | $1,001 - $15,000 |
| Nov 8, 2022 | Christopher L. Jacobs | R | Buy | $1,001 - $15,000 |
| Jul 7, 2020 | Tom Malinowski | D | Buy | $1,001 - $15,000 |
| Dec 8, 2019 | Tom Malinowski | D | Purchase | $1,001 - $15,000 |
| Feb 27, 2018 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
Across the 6 disclosed congressional trades in BioLife Solutions, Inc. (BLFS), members of Congress have reported 2 buys and 2 sells. The average 30-day alpha vs. the S&P 500 is 9.68%.
As of July 2022, BioLife Solutions, Inc. has 1 federal contract award record on file from USAspending.gov — most recently $150K from the Department of Health and Human Services on 2022-07-27.
| Award date | Agency | Amount |
|---|---|---|
| 2022-07-27 | Department of Health and Human Services · National Institutes of Health | $150K |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, BioLife Solutions, Inc. reported revenue of $143.3M and net income of -$66.4M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $28.5M, net income $45.1M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.